
NYSE:BF.B
This summary was created by AI, based on 1 opinions in the last 12 months.
Brown-Forman, a notable player in the liquor industry, faces challenges as younger consumers increasingly prioritize fitness over alcohol consumption. The rise of weight-loss drugs has also posed a threat to liquor companies, further complicating their prospects. Despite these headwinds, Brown-Forman's shares have surged by 10% this year, indicating a resilience in investor confidence. Analysts are keen to see how the upcoming earnings report will reflect the company's ability to adapt to changing consumer preferences while maintaining growth. The juxtaposition of these trends suggests a complex landscape for traditional beverage stocks like Brown-Forman, which may need to reassess their strategies moving forward.
Millennials are not drinking as much as the older generations. Maybe they're not going out as much. This industry performs better in recessions. Though an excellent franchise, the stock hasn't gone anywhere. Chinese sanctions hurt Brown. Also, paying in CAD adds a 40% premium. The LCBO boycott will have an impact.
They've missed five-straight quarters, but the most recent one beat cleanly top and bottom. Organic sales grew 3%, instead of an expected decline, for instance. Also, they shaved their full-year capital expenditures outlook, also positive. Successful brands: Woodford Reserve, Diplomatico Rum and Jack Daniels. Struggling are both tequila brands, though (too much competition in the U.S.). Overall, a good report and shares popped after the report.
He used to like this stock, but has reversed his position. Brown's liquor are no longer in style. They reported Dec. 6 sales and earnings coming in light and, worse, they slashed their full-year forecast. Stocks plunged 10% in a session and have rebounded, but still you should ring the register. Their traditional markets (namely the U.S.) are flat, and only emerging markets are up
(Top Pick May 18/17, Down 8.22%) It was interesting at the time. There was speculation they would be bought out. He bought it because he liked the company regardless. The stock came back down to normal. He would not buy it because of speculation it would be bought out. He would not change his mind on this one. He still likes it. He likes the consistency. They have some strong brands and the stock is chronically undervalued.
Brown-Forman is a American stock, trading under the symbol BF.B (previously BF.B-N on Stockchase) on the New York Stock Exchange (BF.B). It is usually referred to as NYSE:BF.B or BF.B
In the last year, there was no coverage of Brown-Forman published on Stockchase.
Brown-Forman was recommended as a Top Pick by Matt Kacur on 2017-05-18. Read the latest stock experts ratings for Brown-Forman.
Earnings reports or recent company news can cause the stock price to drop. Read stock experts' recommendations for help on deciding if you should buy, sell or hold the stock.
In the last year, there was no coverage of Brown-Forman published on Stockchase.
On 2026-06-08, Brown-Forman (BF.B) stock closed at a price of $26.44.
They report Wednesday. The young would rather exercise than drink and the weight-loss drugs have hurt liquor companies. But why are shares up 10% this year?